The next COVID challenge – mass immunisation

In the last few days, Pfizer BioNTech a German-US company, and the US company Moderna have separately announced that that the COVID-19 vaccines they have been developing have proved ninety-five per cent effective.

The article The next COVID challenge – mass immunisation appeared first on Stabroek News.